Concepedia

Antonio Cannatà

AC

65

Publications

3.7K

Citations

33

H-Index

2012

Active since

Affiliations

University of Trieste(Current)

King's College London

Azienda Sanitaria Universitaria Integrata di Trieste

British Heart Foundation

Mario Negri Institute for Pharmacological Research

Antonio Cannatà is an author at University of Trieste specializing in medicine, cardiovascular disease, and cardiology.

ORCID

Top concepts

Publications per year

2012–2025

65

Publications

65

Drugs that inhibit TMEM16 proteins block SARS-CoV-2 spike-induced syncytia

Luca Braga, Hashim Ali, Ilaria Secco et al. · Nature · 2021 · 435 citations · Full text

, , +4

Glomerular Hyperfiltration and Renal Disease Progression in Type 2 Diabetes

Piero Ruggenenti, Esteban Porrini, Flavio Gaspari et al. · Diabetes Care · 2012 · 313 citations · Full text

Early detection of diabetic kidney disease by urinary proteomics and subsequent intervention with spironolactone to delay progression (PRIORITY): a prospective observational study and embedded randomised placebo-controlled trial

Nete Tofte, Morten Lindhardt, Katarina Adamova et al. · The Lancet Diabetes & Endocrinology · 2020 · 247 citations · Full text

, , +8

Prevalence, Characteristics, and Outcomes of COVID-19–Associated Acute Myocarditis

Enrico Ammirati, Laura Lupi, Matteo Palazzini et al. · Circulation · 2022 · 219 citations · Full text

The Impact of COVID-19 on Heart Failure Hospitalization and Management: Report from a Heart Failure Unit in London During the Peak of the Pandemic

Daniel I. Bromage, Antonio Cannatà, Irfan Ali Rind et al. · European Journal of Heart Failure · 2020 · 192 citations · Full text

Rows per page

1–5 of 65